175 related articles for article (PubMed ID: 35639475)
41. High Discontinuation Rates of Peroral ASA Treatment for CRSwNP: A Real-World Multicenter Study of 171 N-ERD Patients.
Laulajainen-Hongisto A; Turpeinen H; Vento SI; Numminen J; Sahlman J; Kauppi P; Virkkula P; Hytönen M; Toppila-Salmi S
J Allergy Clin Immunol Pract; 2020; 8(10):3565-3574. PubMed ID: 32693216
[TBL] [Abstract][Full Text] [Related]
42. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
Simon RA; Dazy KM; Waldram JD
Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
[TBL] [Abstract][Full Text] [Related]
43. Symptom Control of Patients With Chronic Rhinosinusitis With Nasal Polyps Under Maintenance Therapy With Daily Acetylsalicylic Acid.
Hahn J; Appel H; Scheithauer MO; Petereit F; Greve J; Lindemann J; Hoffmann TK; Veit JA; Sommer F
Am J Rhinol Allergy; 2020 Jul; 34(4):554-563. PubMed ID: 32208749
[TBL] [Abstract][Full Text] [Related]
44. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
Cousins K; Chen CC; Sehanobish E; Jerschow E
Adv Pharmacol; 2023; 97():423-444. PubMed ID: 37236766
[TBL] [Abstract][Full Text] [Related]
45. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
White AA; Stevenson DD
Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
[TBL] [Abstract][Full Text] [Related]
46. Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis.
Marquette M; Tailor BV; Calder PC; Curtis PJ; Loke Y; Wilson AM
Curr Allergy Asthma Rep; 2022 Dec; 22(12):209-229. PubMed ID: 36374376
[TBL] [Abstract][Full Text] [Related]
47. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Berges-Gimeno MP; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
[TBL] [Abstract][Full Text] [Related]
48. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
[TBL] [Abstract][Full Text] [Related]
49. Eicosanoid imbalance correlates in vitro with the pattern of clinical symptoms of Samter's triad.
Forster U; Strathmann S; Schafer D; Szczepek AJ; Olze H
Rhinology; 2013 Mar; 51(1):61-9. PubMed ID: 23441313
[TBL] [Abstract][Full Text] [Related]
50. [Family study of patients with aspirin intolerance and rhinosinusitis].
May A; Wagner D; Langenbeck U; Weber A
HNO; 2000 Sep; 48(9):650-4. PubMed ID: 11056852
[TBL] [Abstract][Full Text] [Related]
51. Aspirin-Exacerbated Respiratory Disease.
Walgama ES; Hwang PH
Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
[TBL] [Abstract][Full Text] [Related]
52. Samter's triad with aural involvement: a novel approach to management.
Sethukumar P; Heywood R; Narula A
J Laryngol Otol; 2014 Dec; 128(12):1114-6. PubMed ID: 25418960
[TBL] [Abstract][Full Text] [Related]
53. Transcriptome Analysis Identifies Doublesex and Mab-3 Related Transcription Factor (DMRT3) in Nasal Polyp Epithelial Cells of Patients Suffering from Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease (AERD).
Priyadharshini VS; Jiménez-Chobillon MA; de Graaf J; Porras Gutiérrez de Velasco R; Gratziou C; Ramírez-Jiménez F; Teran LM
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439758
[TBL] [Abstract][Full Text] [Related]
54. [Aspirin-Intolerance-Syndrom : a common and interdisciplinary disease].
Umbreit C; Virchow JC; Thorn C; Hörmann K; Klimek L; Pfaar O
Internist (Berl); 2010 Sep; 51(9):1196-8, 1200-1. PubMed ID: 20725708
[TBL] [Abstract][Full Text] [Related]
55. The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety.
Buchheit K; Bensko JC; Lewis E; Gakpo D; Laidlaw TM
World J Otorhinolaryngol Head Neck Surg; 2020 Dec; 6(4):203-206. PubMed ID: 33336174
[TBL] [Abstract][Full Text] [Related]
56. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
[TBL] [Abstract][Full Text] [Related]
57. Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease - a randomized crossover trial.
Sowerby LJ; Patel KB; Schmerk C; Rotenberg BW; Rocha T; Sommer DD
J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):27. PubMed ID: 33892819
[TBL] [Abstract][Full Text] [Related]
58. Dysbiosis in aspirin-exacerbated respiratory disease.
Cook KA; Domissy A; Simon RA; White AA; Modena BD
Int Forum Allergy Rhinol; 2021 Jul; 11(7):1116-1120. PubMed ID: 33438331
[No Abstract] [Full Text] [Related]
59. Risk factors for severe adult-onset asthma: a multi-factor approach.
Toppila-Salmi S; Lemmetyinen R; Chanoine S; Karjalainen J; Pekkanen J; Bousquet J; Siroux V
BMC Pulm Med; 2021 Jul; 21(1):214. PubMed ID: 34238263
[TBL] [Abstract][Full Text] [Related]
60. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
